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============

Tuberculosis (TB) is the leading cause of death due to a single infectious agent worldwide. As per a World Health Organization (WHO) report, an estimated 10 million people developed TB in 2017 ([@B1]). The emergence of strains of multidrug-resistant tuberculosis (MDR-TB) that are resistant to the most effective drugs (rifampin and isoniazid) poses a threat to TB control programs. These constitute 82% of the 558,000 rifampin-resistant cases reported in 2017 worldwide. Among the MDR-TB cases, 8.5% are identified as extensively drug-resistant TB (XDR-TB) and have additional resistance to one of the fluoroquinolones and aminoglycosides. India alone contributed to 2,650 notified cases of XDR-TB in 2017 ([@B1], [@B2]). Early and accurate diagnosis of MDR and XDR-TB followed by appropriate treatment is of critical importance if the number of new cases is to be reduced worldwide. Here, we describe the use of whole-genome sequencing (WGS) technology to define the genetic mutations in isolates from a part of the world that lacks such data and which could contribute to the genetic prediction of a tailored treatment regimen for TB patients in the future.

We report the whole-genome sequence of 16Mycobacterium tuberculosis isolates from patients in Chennai, India. These have a range of drug resistance patterns that categorize them as MDR, polydrug-resistant (PDR), or XDR. In order to obtain the mycobacterial DNA for WGS, M. tuberculosis strains were isolated from sputum samples of pulmonary tuberculosis patients treated at NIRT, Chennai and grown on Lowenstein-Jensen (LJ) medium, and colonies were scraped from the 3+ growth on the medium into Tris-ethylenediaminetetraacetic acid (TE) buffer ([@B3][@B4][@B5]) followed by genomic DNA extraction with a cetyltrimethylammonium bromide-sodium chloride (CTAB--NaCl) extraction method ([@B6]). Drug susceptibility of the M. tuberculosis isolates was tested with an automated MGIT 960 instrument as per the manufacturer's protocol ([@B7], [@B8]). DNA purity and concentration were determined with Nanodrop ([@B9]) and Qubit 3.0 fluorometers, respectively ([@B10]). Library preparation was performed with the NEXTFLEX DNA library kit as defined by the manufacturer's protocol ([@B11]). Briefly, genomic DNA was sheared to generate fragments of approximately 200 to 600 bp. The fragment size distribution was checked using an Agilent Bioanalyzer (Agilent Technologies) according to the manufacturer's instructions ([@B12]). These adapter ligated fragments were subjected to 10 rounds of PCR with primers provided in the NEXTFLEX DNA sequencing kit. The libraries were quantified using quantitative PCR (qPCR, KAPA library quantification kit, Kappabiosystems) normalized to 1 nM and denatured with 0.1 N NaOH before sequencing with MiSeq v2 cluster chemistry (Illumina). Raw sequence reads were filtered with Trimmomatic v0.36 ([@B13]) (quality \>20) and assembled with SPAdes v3.11.0 ([@B14]) with default parameters, and the contigs larger than 500 bp were filtered for further analysis. The filtered reads were also aligned to H37Rv (GenBank accession number [NC_000962](https://www.ncbi.nlm.nih.gov/nuccore/NC_000962)) using bwa v0.7.12 ([@B15]). The alignment obtained was processed for correction of alignments at indels by the local realignment with a combination of Picard v2.2.4 (<http://broadinstitute.github.io/picard/>) and GATK v3.5 ([@B16]). The variants were identified with SAMtools v1.3.1 ([@B17]) and were filtered based on the following parameters: base quality greater than 50, depth greater than 20, mapping quality greater than 30, and alternate allele proportion greater than 75%. The variants were further annotated using a custom Python script (<https://github.com/kumarnaren/mtb_vcf_annotator>).

[Table 1](#tab1){ref-type="table"} lists the characteristics of the 16 genomes that were sequenced. The complete length of the assembled genomes ranged from 4,220,229 to 438,963 bp, with coverage depth ranging from 52× to 198×. Examination of the genetic variants revealed the presence of the well-known mutations S315T in *katG* and S450L in *rpoB* ([@B18], [@B19]) to be the predominant mutations in isoniazid- and rifampin-resistant isolates, respectively. Isolates were assigned to lineages 1 to 4 based on the presence or absence of phylogenetic single nucleotide polymorphisms (SNPs) reported by Coll et al. ([@B18]). Lineage 1 was dominant in our collection of 16 isolates, which is consistent with our previous reports ([@B3], [@B5]) based on spoligotyping and WGS of drug-susceptible clinical isolates of M. tuberculosis.

###### 

Summary of sequence details, drug resistance category, and lineage prediction for M. tuberculosis isolates

  NCBI identification no.[^*a*^](#ngtab1.1){ref-type="table-fn"}   Assembly accession no.                                              Coverage depth (×)   Read length (bp)   GC content (%)   *N*~50~ value (bp)   No. of contigs \>500   Genome size (bp)   Reference coverage (H37Rv) (%)   No. of tRNAs   No. of rRNAs   No. of coding DNA sequences   Lineage
  ---------------------------------------------------------------- ------------------------------------------------------------------- -------------------- ------------------ ---------------- -------------------- ---------------------- ------------------ -------------------------------- -------------- -------------- ----------------------------- ---------
  NIRTX002_PDR                                                     [SDOU00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOU00000000)   74                   151                65.58            90,381               103                    4,220,229          99.3                             44             0              3,997                         1
  NIRTX003_XDR                                                     [SDOT00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOT00000000)   131                  151                65.58            98,656               107                    4,375,554          99.2                             45             3              4,139                         3
  NIRTX004_XDR                                                     [SDOS00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOS00000000)   79                   100                65.35            57,187               136                    4,233,503          96.3                             45             2              4,112                         4
  NIRTX005_XDR                                                     [SDOR00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOR00000000)   80                   150                65.37            60,784               140                    4,262,450          96.8                             45             4              4,163                         4
  NIRTX006_XDR                                                     [SDOQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOQ00000000)   75                   76                 65.59            98,740               114                    4,350,302          98.6                             45             3              4,119                         2
  NIRTX007_PDR                                                     [SDOP00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOP00000000)   85                   76                 65.58            85,411               133                    4,389,631          99.5                             45             3              4,145                         1
  NIRTX008_XDR                                                     [SDOO00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOO00000000)   52                   76                 65.67            114,871              89                     4,300,325          97.5                             45             1              4,068                         4
  NIRTX009_XDR                                                     [SDON00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDON00000000)   91                   76                 65.59            108,252              91                     4,379,992          99.3                             45             3              4,103                         1
  NIRTX010_PDR                                                     [SDOM00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOM00000000)   69                   76                 65.61            72,683               127                    4,329,145          98.1                             45             3              4,118                         2
  NIRTX011_XDR                                                     [SDOL00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOL00000000)   60                   76                 65.59            115,334              96                     4,384,136          99.4                             45             3              4,113                         1
  NIRTX015_MDR                                                     [SDOK00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOK00000000)   198                  76                 65.59            105,690              109                    4,366,330          99.0                             45             3              4,113                         1
  NIRTX016_MDR                                                     [SDOJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOJ00000000)   71                   76                 65.59            104,750              99                     4,378,706          99.3                             45             3              4,123                         1
  NIRTX019_MDR                                                     [SDOI00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOI00000000)   53                   76                 65.56            97,386               98                     4,370,427          99.1                             45             3              4,113                         1
  NIRTX022_MDR                                                     [SDOH00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOH00000000)   174                  151                65.61            94,182               101                    4,362,069          98.9                             45             3              4,136                         4
  NIRTX024_MDR                                                     [SDOG00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOG00000000)   68                   151                65.56            105,728              92                     4,383,766          99.4                             45             3              4,152                         1
  NIRTX025_MDR                                                     [SDOF00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOF00000000)   92                   151                65.54            25,670               323                    4,380,819          99.9                             49             8              4,295                         1

MDR, multidrug-resistant TB; XDR, extensively drug-resistant TB; PDR, polydrug-resistant TB.

The sequenced genomes of these isolates will contribute toward an understanding of the genomic characteristics of strains of M. tuberculosis that are prevalent in India, including the genetic mutations that cause resistance. In particular, these data add to knowledge about isolates from South India and provide a resource for future studies of M. tuberculosis in the region.

Data availability. {#s1.1}
------------------

The whole-genome sequence reads of the Mycobacterium tuberculosis isolates reported here are deposited in the Sequence Read Archive (SRA) under accession number [PRJNA492975](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA492975). This whole-genome shotgun project (assembly) has been deposited in GenBank under the accession numbers [SDOF00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOF00000000) to [SDOU00000000](https://www.ncbi.nlm.nih.gov/nuccore/SDOU00000000). The versions described in this paper are accession numbers SDOF01000000 to SDOU01000000.
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